Merck KGaA (MKGAF)

Market Cap	59.44B
Revenue (ttm)	21.90B
Net Income (ttm)	2.88B
Shares Out	n/a
EPS (ttm)	6.61
PE Ratio	20.67
Forward PE	n/a
Dividend	2.50 (1.79%)
Ex-Dividend Date	Apr 28, 2025

Volume	275
Average Volume	381
Open	143.19
Previous Close	141.93
Day's Range	143.17 - 143.19
52-Week Range	118.05 - 200.56
Beta	0.64
RSI	53.64
Earnings Date	May 15, 2025

About Merck KGaA

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector. This segment provides drug manufacturers with process development expertise and technologies, such as continuous bioprocessing; testing kits and services; reagents and services; testing solutions that analyze air, water, and soil; and testing a...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1668
• Employees: 59,020
• Stock Exchange: OTCMKTS
• Ticker Symbol: MKGAF

Financial Performance

In 2024, Merck KGaA's revenue was 21.16 billion, an increase of 0.78% compared to the previous year's 20.99 billion. Earnings were 2.78 billion, a decrease of -1.66%.

Financial numbers in EUR